Navigation Links
University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
Date:10/1/2008

SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego-based medical device company, today announced that it has shipped its non-invasive WavSTAT(R) Optical Biopsy System to the University of Southern California to demonstrate the clinical value of the Optical Biopsy System as an adjunctive tool to improve clinical sensitivity in identifying dysplasia or cancer in the esophagus. This marks the final phase of a study which has been conducted over the past three years.

Earlier this month, SpectraScience announced that it had delivered WavSTAT Systems to the Mayo Clinic and San Diego VA Hospital for similar studies. Other participants in the study include Minnesota Gastroenterology, P.A. and the Boston University VA Hospital.

Jim Hitchin, CEO of SpectraScience, commented, "We are pleased to be moving forward with our clinical study to demonstrate the value of the WavSTAT System in screening for esophageal cancers and pre-cancers, and believe that the System can be instrumental in helping doctors more reliably and efficiently detect pre-cancerous tissue at sufficiently early stages to provide more effective treatment."

WavSTAT Overview

The WavSTAT Optical Biopsy System was approved by the FDA in November of 2000 as safe and effective for adjunctive use during endoscopy of the colon to improve a physician's sensitivity to identify pre-cancerous polyps. The System also received the CE Mark in Europe in September 2007. The approved WavSTAT System uses a low power, non-significant risk laser to scan tissue and instantaneously help the physician determine whether small polyps are normal or pre-cancerous without physically removing the tissue. If polyps are determined to be pre-cancerous, they can be removed during the same procedure.

Current standards of care dictate that if a patient has severe chronic symptoms of heartburn, an endoscopy of the esophagus may be warranted and, if indi
'/>"/>

SOURCE SpectraScience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
2. University of Pennsylvania scientists move optical computing closer to reality
3. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
4. Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop Designer Transplants
5. University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence
6. CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
7. Most developing countries ill-equipped to ensure global biosafety: UN University
8. Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario
9. University of Pennsylvania engineers reveal what makes diamonds slippery at the nanoscale
10. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
11. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Dec. 2 Martek Bioscien...hat it intends to release the results of its fourt...9, at approximately 4:00 p.m. Eastern Time (ET). ... conduct a conference call to discuss these result...en to the call live via webcast by visiting Martek...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Neurostimulation - A Global...r.com/p0164232/Neurostimulation---A-Global-Market-...n market stands enthused by the growing base of ag...ted diseases such as, Parkinson,s, and Alzheimer,s...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Drug Discovery Technologies...ities ,, http://www.reportlinker.com/p0164246...Market-Trends--Opportunities.html ,, Drug disc...f every pharmaceutical company,s business strategy...
(Date:12/2/2009)...c. 2 The world,s first concept dem...y, a breakthrough alternative to replace a petroch... synthetic rubber with renewable biomass, made the...re will be on display at a lounge in the common de...rt throughout December 21, while the other tire wi...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...nce,Authority has launched a $2.5 million initiati...ate products that protect Americans from the,inten... national economy or,to infect humans., The goals...tiative,(CBRI) are to support interinstitutional r...n-animal diseases; (2) provide advanced test and,e...
... 13th Annual Healthcare Conference, SAN DIEGO, Ja...ice company focused on the treatment of cardiac,ar...ts Cardiac Cryoablation,System and its next genera...ial Fibrillation Symposium, January 17-19, 2008. C...In August 2007, the FDA approved the Cryoablation ...
...the,Federal Drug Administration,s announcement tod... for human consumption, Smithfield Foods, Inc.,(NY...company is not planning,to produce meat products f...g animals is relatively new. As thoughtful leaders...er scientific research on this technology., Throu...
Other Biology Technology:Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally 2Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally 3CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 3
(Date:12/2/2009)...HILADELPHIA Mexican-American adolescents exposed ...ely to pick up the habit themselves, and this may ...th smoking initiation, according to new study find...ing in the United States and highlights the global...ramework Convention on Tobacco Control, which incl...
(Date:12/2/2009)...LADELPHIA Assurance of a cancer-free status did n...uterized tomography (CT) lung-cancer screening pro...s wrote in a study published in Cancer Epidemiolo...rican Association for Cancer Research. The Decembe...hese findings should negate widespread concern in ...
(Date:12/2/2009)...ecalls of ground beef, peanut butter, and other fo... concern about food safety. They also are quietly ...pment and fostering new food safety regulations. T... current issue of Chemical & Engineering News , (... Editor Jyllian Kemsley and Senior Correspondent M...
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 1Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 2Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 3Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 4American College of Cardiology Launches the Nations First Registry Based Cardiovascular Practice Network 5700 1American College of Cardiology Launches the Nations First Registry Based Cardiovascular Practice Network 5700 2American College of Cardiology Launches the Nations First Registry Based Cardiovascular Practice Network 5700 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10
...gilent Technologies Inc. (NYSE: A) today announced...design, probe sequence and annotation information ...formation is expected to improve cross-laboratory ...arison. , "Full release of the probe sequences is ...to take," said Catherine Ball, president of the Mi...
...UHC researchers have defined genetic resistance to...mber of the viral group that causes some of the wo...cken pox and mononucleosis. The groundbreaking res...ides a roadmap for the development of human therap...atients and improve the success of transplant surg...
...he telltale paw prints with huge 10 centimetre-lon...ating DNA evidence seals the case of the most nort...els mounting evidence that Canada,s High Arctic is...Nanuk is having to make room for its southern cous...ear (Ursus arctos) was discovered on Melville Isla...
Other Biology News:Virus-host interactions at sea effect global photosynthesis 2MUHC scientists describe genetic resistance to rampant virus 2Grizzlies set to invade high Arctic? 2
Mouse Anti-Cig2 Monoclonal Antibody, Unconjugated, Clone CIG 3A11 / 5 from Abcam
Rabbit Anti-CD18, phospho (Ser756 / Thr758 / Thr759) Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Goat Anti-Human SART1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Cyclin D1, phospho (Thr286) Antibody, Unconjugated from Cell Signaling Technology
Biology Products: